# Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy

> **NCT05241119** · NA · RECRUITING · sponsor: **Shengjing Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** SLNB
- **PROCEDURE:** pALND
- **PROCEDURE:** ALND

## Key facts

- **NCT ID:** NCT05241119
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05241119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05241119, "Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05241119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*